Insiders Updates
CHRS short interest fall by -1.28%, reflecting positive sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Coherus Oncology
In a filing, Coherus Oncology Inc revealed its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23
Coherus Oncology Inc’s recently made public that its Director Wahlstrom Mats unloaded Company’s shares for reported $73881.0 on May 23